Infusion Associates' First Aduhelm Patient (2)

First Patient in West Michigan Receives Biogen Alzheimer’s Drug at Infusion Associates Outpatient Infusion Center

Grand Rapids, Mich. – Aug. 23, 2021 – Infusion Associates (IA), a leading provider of medically prescribed outpatient infusion therapy, today has completed their first Aduhelm (aducanumab-avwa) infusion for a patient at their Grandville, Michigan location. Infusion Associates is the first organization in West Michigan to administer the new FDA approved drug treating Alzheimer’s disease. The U.S. Food & Drug Administration granted approval of Aduhelm, also […]

READ MORE
NIH COVID-19 Study - Infusion Associates

Infusion Associates Begins Recruiting Patients in Michigan for COVID-19 Research Study

Local outpatient infusion therapy provider participating in international COVID-19 study OTAC: Outpatient Treatment with Anti-Coronavirus Immunoglobulin Grand Rapids, Mich. – Aug. 10, 2021 – Infusion Associates (IA), a leading provider of medically prescribed outpatient infusion therapy, has begun recruiting patients across Michigan for an international COVID-19 study sponsored by the National Institute of Allergy and […]

READ MORE